NASDAQ · BFRI
Biofrontera Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for BFRI: Nov 11, 2026
Biofrontera Inc. Common Stock is estimated to report earnings on 11/11/2026. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. According to Zacks Investment Research, based on 1 analysts' forecasts, the consensus EPS forecast for the quarter is $-0.33. The reported EPS for the same quarter last year was $-0.59.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $-0.33 | $-0.33 | $-0.33 | 1 |
| Dec 2026 | $0.16 | $0.16 | $0.16 | 1 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
RTTNews · The Motley Fool · Zacks- RTTNews · Oct 8, 10:39 AM EDTBiofrontera Files SNDA To Expand Ameluz Use In Actinic Keratosis; Stock Down(RTTNews) – Biofrontera Inc. (BFRI), a biopharmaceutical company specializing in the development and commercialization of photodynamic therapy (PDT) in dermatology, on Thursday announced that it has submitted a supplemental New Drug Application (sNDA) to the U.S. FDA seeking to e
- RTTNews · Oct 8, 9:47 AM EDTBiofrontera Submits Ameluz SNDA For Expanded Actinic Keratosis Use(RTTNews) – On Thursday, Biofrontera Inc. (BFRI) said it has submitted a supplemental New Drug Application (sNDA) to the U.S. FDA seeking to expand the approved use of Ameluz in combination with photodynamic therapy (PDT) for the treatment of actinic keratoses (AKs).
- RTTNews · Sep 18, 3:27 PM EDTBiotech Stocks In Focus – IMCC +245%, XRTX +12%, SILO, BFRI(RTTNews) – The following biotech and healthcare stocks were in focus on Friday following significant share-price moves and company updates.
- RTTNews · Sep 14, 10:08 AM EDTBiofrontera Stock Drops 6% Despite Securing FDA Approval For Ameluz SNDA(RTTNews) – Monday, Biofrontera Inc. (BFRI) announced that the U.S. Food and Drug Administration has approved its supplemental New Drug Application for Ameluz topical gel, 10%, in combination with photodynamic therapy using the BF-RhodoLED lamp series, for the treatment of superf
- RTTNews · Sep 8, 12:11 AM EDTISpecimen In Focus, Genelux Nears Phase 3 Ovarian Cancer Data, Biofrontera Awaits FDA Decision(RTTNews) – The biotech and pharma stocks to watch on Tuesday include iSpecimen, which gained more than 37% in overnight trading on Monday despite no specific news; Genelux, with a key clinical catalyst for its lead candidate Olvi-Vec expected in the coming months; Anixa Bioscien
- RTTNews · Sep 7, 10:28 PM EDTBiotech Stocks At 52-Week Highs – PDEX +18% On FY'26 Results, ODTX +8%, EOLS, BFRI, DRTS(RTTNews) – The following biotech stocks reached a 52-week high on September 4, 2026, as various companies reported financial results and anticipated near-term clinical trial readouts.
- RTTNews · Aug 31, 5:01 AM EDTBiotech Stocks At 52-Week Highs – RNXT +12%, BLSM, RVTY, ATRC, BFRI(RTTNews) – The following biotech stocks reached a 52-week high on August 28, 2026, as various clinical trials reported initial data and companies reached certain regulatory milestones.
- RTTNews · Aug 26, 11:11 AM EDTBiotech Stocks Facing FDA Decision In September 2026(RTTNews) – As September ushers in the first hints of autumn, it also brings a packed FDA regulatory calendar.
- The Motley Fool · Aug 20, 11:58 AM EDTBiofrontera (BFRI) Q2 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- RTTNews · Aug 13, 3:50 PM EDTBiofrontera Posts Strong Q2 2026 Results On 33% Revenue Growth(RTTNews) – Biofrontera Inc. (BFRI), a U.S. biopharmaceutical company focused on dermatology and photodynamic therapy (PDT), reported second-quarter 2026 results showing sharp improvement in revenues and profitability compared with the prior year.
- Zacks · Aug 13, 10:10 AM EDTBiofrontera Inc. (BFRI) Reports Q2 Loss, Beats Revenue EstimatesBiofrontera Inc. (BFRI) delivered earnings and revenue surprises of +70.59% and +33.37%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Aug 12, 5:40 PM EDTBioStem Technologies, Inc. (BSEM) Reports Q2 Loss, Beats Revenue EstimatesBioStem Technologies, Inc. (BSEM) delivered earnings and revenue surprises of -4.00% and +23.43%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Financials
Loading fundamental data…
More headlines
More stories for Biofrontera Inc. from TradingView. Coverage varies.
Loading related news…
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.